End-of-day quote
Other stock markets
|
||
- EUR | 0.00% |
Mar. 26 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
Mar. 12 | SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating | ZD |
Chart calendar Sartorius Stedim Biotech SA
Upcoming events on Sartorius Stedim Biotech SA
Past events on Sartorius Stedim Biotech SA
2024-03-26 07:00 am | Annual General Meeting |
2024-01-26 07:00 am | Q4 2023 Earnings Call |
2024-01-26 01:00 am | Q4 2023 Earnings Release |
2023-10-19 06:30 am | Q3 2023 Earnings Call |
2023-10-19 01:00 am | Q3 2023 Earnings Release |
2023-09-07 | Wells Fargo Healthcare Conference |
2023-09-04 | Commerzbank & ODDO BHF Corporate Conference |
2023-07-21 09:30 am | Q2 2023 Earnings Call |
2023-07-21 01:00 am | Q2 2023 Earnings Release |
2023-06-20 | Deutsche Bank dbAccess Conference |
2023-05-31 | Kepler Cheuvreux ESG Virtual Conference |
2023-05-24 | Gilbert Dupont Midcaps Forum |
2023-05-10 | Redburn Toronto Conference |
2023-05-08 | Bank of America Healthcare Conference |
2023-04-20 09:30 am | Q1 2023 Earnings Call |
2023-04-20 01:00 am | Q1 2023 Earnings Release |
2023-04-05 08:00 am | Acquisition of Polyplus by Sartorius Stedim Biotech Call |
2023-03-29 | Ex-dividend day for final dividend |
2023-03-27 08:00 am | Annual General Meeting |
2023-01-26 09:30 am | FY 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1 441 1 435 0.39% | 1 910 1 910 -0.02% | 2 887 2 877 0.35% | 3 493 3 500 -0.21% | 2 776 2 789 -0.48% | 3 004 |
EBITDA Million EUR | Released Forecast Spread | 422 423 -0.29% | 605 589 2.63% | 1 033 1 039 -0.55% | 1 221 1 212 0.75% | 785 773 1.56% | 924 |
EBIT Million EUR | Released Forecast Spread | 332 355 -6.54% | 472 485 -2.77% | 865 879 -1.5% | 1 040 1 057 -1.66% | 0,00 597 - | 679 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 318 343 -7.51% | 483 460 4.9% | 647 847 -23.67% | 1 130 1 158 -2.36% | 0,00 503 - | 544 |
Net income Million EUR | Released Forecast Spread | 235 252 -6.99% | 358 341 4.99% | 414 595 -30.37% | 876 858 2.15% | 310 341 -9.24% | 359 |
EPS EUR | Released Forecast Spread | 2,54 2,74 -7.34% | 3,88 3,67 5.6% | 4,50 6,38 -29.49% | 9,51 9,20 3.4% | 3,36 3,73 -9.95% | 3,80 |
Announcement Date | 28/01/20 | 18/02/21 | 27/01/22 | 26/01/23 | 26/01/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1 352 668 102.53% | 779 765 1.85% | 863 791 9.06% | 862 861 0.1% | 878 944 -6.95% | 890 906 -1.74% | 726 851 -14.65% | 676 756 -10.59% | 667 693 -3.79% | 707 679 4.07% | 733 | 738 | 771 | 759 | |||
EBITDA Million EUR | Released Forecast Spread | 487 246 98.53% | 268 265 0.98% | 304 280 8.64% | 303 311 -2.57% | 305 320 -4.73% | 310 307 0.73% | 220 293 -24.96% | 196 226 -13.53% | 178 209 -14.7% | 191 185 3.69% | 200 | 219 | 247 | 254 | |||
EBIT Million EUR | Released Forecast Spread | 165 188 -12.51% | 265 276 -3.84% | 221 230 -3.68% | 451 431 4.83% | 263 245 7.56% | 261 280 -7.08% | 263 289 -9.19% | 253 267 -5.22% | 172 266 -35.48% | 145 176 -17.36% | 76,9 171 -54.95% | 150 | 160 | 179 | 207 | 201 | |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 63,8 221 -71.1% | 338 210 61.21% | 283 258 9.9% | 274 268 2.03% | 236 289 -18.26% | 149 262 -43.35% | 159 170 -6.35% | 35,5 175 -79.68% | 105 | 125 | 144 | 172 | 166 | ||||
Net income Million EUR | Released Forecast Spread | 8,21 159 -94.84% | 270 164 64.81% | 215 197 9.03% | 205 195 4.71% | 187 211 -11.61% | 111 194 -42.76% | 133 127 4.59% | 25,7 131 -80.39% | 39,8 63,5 -37.28% | 76,6 | 90,5 | 111 | 75,3 | ||||
EPS EUR | Released Forecast Spread | 0,09 1,72 -94.78% | 2,93 1,77 65.16% | 2,33 2,14 9.02% | 2,22 2,12 4.76% | 2,03 2,30 -11.76% | 1,21 1,97 -38.67% | 1,44 1,31 9.89% | 0,28 1,42 -80.3% | 0,43 0,69 -37.67% | 0,83 | 0,98 | 1,21 | 0,82 | ||||
Announcement Date | 28/01/20 | 18/02/21 | 21/07/21 | 27/01/22 | 27/01/22 | 21/04/22 | 21/07/22 | 19/10/22 | 26/01/23 | 20/04/23 | 21/07/23 | 19/10/23 | 26/01/24 | - | - | - | - |
2024-04-07 | MANI, INC.: Q2 2024 Earnings Release |
2024-04-08 | NEOGEN CORPORATION: Q3 2024 Earnings Release |
2024-04-08 | NINGBO DAVID MEDICAL DEVICE CO., LTD.: Q4 2023 Earnings Release |
2024-04-11 01:00 am | GERRESHEIMER AG: Q1 2024 Earnings Release |
2024-04-15 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q4 2023 Earnings Release |
2024-04-16 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-17 07:30 am | ABBOTT LABORATORIES: Q1 2024 Earnings Release |
2024-04-17 | WELL LEAD MEDICAL CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-18 01:00 am | SARTORIUS STEDIM BIOTECH: Q1 2024 Earnings Release |
2024-04-18 08:00 am | ARJO AB: Q1 2024 Earnings Release |
Past sector events for Sartorius Stedim Biotech SA
Today | SHINVA MEDICAL INSTRUMENT CO.,LTD.: Q4 2023 Earnings Release |
2024-03-28 07:30 am | PERSPECTIVE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-22 | JIANGXI SANXIN MEDTEC CO.,LTD.: Q4 2023 Earnings Release |
2024-03-18 | HLB CO., LTD.: Q4 2023 Earnings Release (Projected) |
2024-03-13 02:00 am | MEDACTA GROUP SA: Q4 2023 Earnings Release |
2024-03-07 | SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 07:00 am | AMPLIFON S.P.A.: Q4 2023 Earnings Release |
2024-03-07 06:30 am | STEVANATO GROUP S.P.A.: Q4 2023 Earnings Release |
2024-03-06 02:00 am | CONVATEC GROUP PLC: Q4 2023 Earnings Release |
2024-03-05 04:05 pm | AGILITI, INC.: Q4 2023 Earnings Release |
- Stock
- Equities
- Stock Sartorius Stedim Biotech
- Stock Sartorius Stedim Biotech SA - Euronext Paris
- Calendar Sartorius Stedim Biotech SA